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Abstract
We previously showed that the serum- and glucocorticoid-inducible kinase 3 (SGK3) increases the AMPA-type glutamate
receptor GluA1 protein in the plasma membrane. The activation of AMPA receptors by NMDA-type glutamate receptors
eventually leads to postsynaptic neuronal plasticity. Here, we show that SGK3 mRNA is upregulated in the hippocampus of
new-born wild type Wistar rats after NMDA receptor activation. We further demonstrate in the Xenopus oocyte expression
system that delivery of GluA1 protein to the plasma membrane depends on the small GTPase RAB11. This RAB-dependent
GluA1 trafficking requires phosphorylation and activation of phosphoinositol-3-phosphate-5-kinase (PIKfyve) and the
generation of PI(3,5)P2. In line with this mechanism we could show PIKfyve mRNA expression in the hippocampus of wild
type C57/BL6 mice and phosphorylation of PIKfyve by SGK3. Incubation of hippocampal slices with the PIKfyve inhibitor
YM201636 revealed reduced CA1 basal synaptic activity. Furthermore, treatment of primary hippocampal neurons with
YM201636 altered the GluA1 expression pattern towards reduced synaptic expression of GluA1. Our findings demonstrate
for the first time an involvement of PIKfyve and PI(3,5)P2 in NMDA receptor-triggered synaptic GluA1 trafficking. This new
regulatory pathway of GluA1 may contribute to synaptic plasticity and memory.
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Introduction
Excitatory neurotransmission has been thoroughly described at
hippocampal synapses, especially those between Schaffer collater-
als and dendrites of CA1 pyramidal neurons [1]. At these synapses,
different subtypes of glutamate receptors, chiefly AMPA and
NMDA receptors, coexist. AMPA-type glutamate receptors are
rapidly shuttled into and out of synapses to strengthen or weaken
their function [1,2,3,4,5]. At resting membrane potentials,
synaptic glutamate evokes an excitatory postsynaptic current
(EPSC) that is mediated almost entirely by AMPA receptors.
Depolarization relieves the Mg
2+ blockade of the NMDA
receptors, hence subsequent EPSCs contain contributions from
both AMPA and NMDA receptors.
At hippocampal synapses, a large increase in intracellular
calcium concentration mediated by NMDA receptors activates
kinases, enhances activity of synaptic AMPA receptors, and
triggers long term potentiation (LTP) [1,5,6,7].
In the CA1 subfield of the hippocampus, a silent synapse is
defined as a synapse in which EPSCs are absent at the resting
membrane potential but become apparent on depolarization.
Silent synapses are thought to reflect the functional presence of
NMDA but not AMPA receptors. Because only AMPA receptors
can conduct current at the resting membrane potential, the
absence of functional postsynaptic AMPA receptors renders a
synapse ‘‘silent’’. Interestingly, manipulations designed to trigger
LTP in the hippocampus also ‘‘unsilence’’ these silent CA1
synapses [3]. Candidate signaling molecules involved in this
complex regulatory mechanism of synaptic plasticity include SGK,
which has been shown before to regulate AMPA receptor plasma
membrane expression [8]. Other candidate proteins that may
affect GluA1 receptor trafficking include RAB family proteins,
which are GTPases involved in vesicle cycling [9]. RAB5, a
monomeric GTPase of the Ras superfamily, has been implicated
in the regulation of early steps in the endocytic pathway, whereas
the RAB11 GTPase is localized at the trans-Golgi network, post-
Golgi vesicles, and the recycling endosome [10,11]. Mammalian
cells and Xenopus laevis oocytes possess and use highly conserved
RAB-dependent trafficking pathways [12]. Endocytosis by RAB5
and plasma membrane-directed transport by RAB11 participate in
the regulation of CFTR chloride channels [13] and the glucose
transporter GLUT4 [14,15]. The RAB-dependent regulation of
GLUT4 also involves the phosphoinositol-3-phosphate-5-kinase
(PIKfyve) that generates the phosphatidylinositol PI(3,5)P2 [16].
PIKfyve is stimulated by protein kinase B, a close relative of
SGK3, phosphorylating serine and threonine residues within a
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identify a novel mechanism involving NMDA receptor-triggered,
SGK3-dependent stimulation of PIKfyve with subsequent forma-
tion of PI(3,5)P2, which modulates RAB11A-facilitated vesicle
transport to the plasma membrane, leading to an increased
abundance of GluA1 receptor subunits in the plasma membrane.
We suggest that this novel mechanism plays a role in the dynamic
regulation of GluA1 at synapses.
Results
SGK3 mRNA is upregulated in hippocampus after NMDA
receptor activation
We have previously shown that SGK3 increases glutamate-
induced GluA1 receptor currents. As a first step to evaluate
whether SGK3 plays a regulatory role in dynamic processes at the
glutamatergic synapses, we determined the mRNA level of SGK3
in hippocampus after pharmacological NMDA receptor stimula-
tion. To examine the SGK3 mRNA level, hippocampal slices were
incubated with 10 mM NMDA for 30 minutes, total RNA was
isolated and quantitative RT-PCR performed. This analysis
revealed a 2.5fold increase of SGK3 mRNA in NMDA-treated
compared to non-treated hippocampal slices (Figure 1).
PIKfyve as a potential candidate molecule for SGK3-
dependent GluA1 regulation
In earlier studies, we showed that phosphoinositol-3-phosphate-
5-kinase (PIKfyve) is involved in SGK1-dependent regulation of
transporters and channels (e.g. EAAT 2, 23, 24, CFTR, ClC2)
[18,19,20,21,22], and that PIKfyve is phosphorylated on Ser318
by SGK1 [23]. However, SGK3 was not tested as a possible
PIKfyve-targeting kinase. Since among the three SGK isoforms
SGK3 provides the most prominent stimulatory effect on GluA1
[8], it was of special interest to investigate whether SGK3
phosphorylates PIKfyve similar to SGK1. Here, we selectively
analyzed the putative phosphorylation site S318 in PIKfyve for
phosphorylation by SGK3 by using a specific antibody directed
against pS318. The Western blot in Figure 2A demonstrates that
SGK3 as well as PKB phosphorylate PIKfyve at position S318,
Figure 1. SGK3 mRNA expression in hippocampus after
pharmacological NMDA receptor stimulation. mRNA levels of
SGK3 before and after incubation of hippocampal slices with 10 mM
NMDA for 30 minutes, determined by quantitative RT-PCR. The
expression data from hippocampus were normalized to the expression
of the housekeeping gene b-actin. The quantitative RT-PCR revealed a
2.560,52 fold increase in SGK3 mRNA in NMDA-treated compared to
non-treated hippocampal slices. Number of experiments n=4.
doi:10.1371/journal.pone.0033889.g001
Figure 2. PIKfyve expression, phosphorylation, and function.
(A) PIKfyve is phosphorylated at Ser318 by SGK3 and at Ser318 by PKB.
Purified recombinant GST-tagged wild-type (WT) or S318A mutant (SA)
of PIKfyve was subjected to Western blotting. Blots were incubated with
rabbit anti-GST antibody (PIKfyve; lower panel), followed by stripping
and reprobing with a rabbit anti-PIKfyve antibody specific for
phosphoserine 318 (apS318; top panel). (B) RT-PCR demonstrating that
PIKfyve is expressed in hippocampus. Lane 1: cDNA from hippocampus,
the two primers bind in exons 19 and 20, respectively, and amplify a
315 bp fragment of PIKfyve; lane 2: control reaction to exclude genomic
contamination; lane 3: control reaction without reverse transcriptase;
lane 4: control reaction without cDNA. (C) The PIKfyve inhibitor
YM201636 and SGK inhibitor EMD638683 suppress the upregulating
effect of SGK3 on GluA1 currents. GluA1 current amplitudes in oocytes
expressing GluA1. Acute injection of purified active SGK3 protein led to
an increase in GluA1 currents. The effects of YM201636 and EMD638683
on GluA1 currents were measured in oocytes before and after acute
injection of SGK3 protein. Significant change to GluA1 control
(p=0.013) is indicated by *. Numbers of oocytes were n=7–36.
doi:10.1371/journal.pone.0033889.g002
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SGK3. However, expression of PIKfyve in brain, especially in
hippocampus, where GluA1 and SGK3 are expressed, has not yet
been demonstrated. Here, we show mRNA expression of PIKfyve in
mouse hippocampal tissue by performing RT-PCR (Figure 2B). To
further analyze the possible modulatory role of PIKfyve in the SGK3-
dependent regulation of GluA1, we recorded current amplitudes from
Xenopus oocytes expressing either GluA1 or GluA1 plus SGK3 before
and after incubation with the PIKfyve inhibitor YM201636 or SGK
inhibitor EMD638683 (Figure 2C). Both inhibitors fully abolished the
stimulating effect of SGK3. The SGK3 effects on GluA1 channel
currents were mimicked by overexpression of PIKfyve and abrogated
by site-directed mutagenesis that replaced PIKfyve Ser318 by Ala,
indicating that PIKfyve is indeed a downstream target of SGK3
(Figure 3). The membrane abundance of GluA1 was determined by
performing an oocyte plasma membrane biotinylation assay with
subsequent SDS gel electrophoresis and Western blotting. For
quantification, we calculated the mean intensity from three different
blots each of which had been normalized to GluA1 expressed alone.
As illustrated in Figure 3C and D, the protein membrane abundance
of GluA1 is increased in oocytes expressing GluA1 together with
SGK3 and PIKfyve as compared to the GluA1 protein abundance in
oocytes expressing GluA1 alone, suggesting modifications in GluA1
trafficking by SGK3/PIKfyve.
Plasma membrane-directed trafficking of GluA1 proteins
requires functional RAB11, phosphorylation-mediated
activation of PIKfyve as well as the generation of PI(3,5)P2
We have shown before that the increase in GluA1 current
amplitudes by SGK3 is a result of enhanced membrane expression
Figure 3. GluA1 function is increased by SGK3 and PIKfyve. (A) Representative current traces measured in Xenopus oocytes in response to
superfusion with 300 mM glutamate plus 100 mM cyclo-thiacide. All currents were measured at 270 mV. Vertical scale-bar, 0,5 mA; horizontal bar, 4 s.
(B) GluA1 current amplitudes in oocytes expressing GluA1, or combinations of GluA1 with SGK3, the inactive form of PIKfyve (PIKfyve(S318A)), or wild
type PIKfyve. Numbers of oocytes are n=20–30. Significant changes (p,0.001) are indicated by *** (p=0.00049; 0.00036; 0.000073, respectively). (C)
Representative samples including controls from uninjected oocytes were biotinylated to isolate plasma membrane GluA1, then separated on an SDS
gel, Western-blotted and probed with a primary rabbit anti-GluA1 antibody. The GluA1 protein has an apparent molecular weight of ,105 kDa. (D)
Bar graph showing relative abundance of GluA1 plasma membrane protein. The band intensity was quantified by densitometric analysis using the
software Scion image.
doi:10.1371/journal.pone.0033889.g003
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regulates vesicle transport of AMPA receptors [4,9,24,25].
Therefore, we tested the importance of Rab11 for the SGK3-
dependent regulation of GluA1. We addressed this issue by
coexpression studies in Xenopus oocytes. As shown in Figure 4,
Rab11 itself had no effect on GluA1 current amplitudes (Figure 4A,
B) nor on GluA1 plasma membrane expression (Figure 4C, D).
However, when a dominant negative mutant of Rab11
(Rab11(S25N)) was coexpressed with GluA1, the stimulation by
PIKfyve or SGK3 was abrogated, suggesting that Rab11 is a
downstream effector of the described SGK3 cascade (Figure 4). In
theory, PIKfyve-dependent regulation of Rab11 could involve
direct phosphorylation of Rab11 by PIKfyve, or stimulation of
Rab11 by the PIKfyve product, PI(3,5)P2. Thus, we performed an
acute injection of a water-soluble analog of PI(3,5)P2 into oocytes
overexpressing GluA1 either alone (Figure 5A), or together with
Rab11 or Rab11(S25N) (Figure 5B). The acute injection of the
lipid PI(3,5)P2 led to a significant increase in GluA1 current
amplitudes for oocytes either expressing GluA1 or GluA1 plus
Rab11. For oocytes expressing GluA1 plus Rab11(S25N) no
stimulatory effect was observed, suggesting that the product of
PIKfyve, PI(3,5)P2, modulates Rab11-dependent trafficking of
GluA1. As mentioned above, others have shown a regulatory role
of Rab11 on GluA1 [25]. In one study, Wang et al. found that
myosin Vb binds to Rab11/Rab11FIP2 (Rab11-family interacting
protein 2). Myosin Vb anchors the complex to the cytoskeleton.
Figure 4. Regulation of GluA1 by SGK3 and PIKfyve is Rab11-dependent. (A) Representative current traces measured in Xenopus oocytes in
response to superfusion with 300 mM glutamate plus 100 mM cyclo-thiacide. All currents were measured at 270 mV. Vertical scale-bar, 0,5 mA;
horizontal bar, 4 s. (B) GluA1 current amplitudes in oocytes expressing GluA1, or combinations of GluA1 with Rab11, the dominant negative form of
Rab11 (Rab11DN), PIKfyve, or SGK3. Numbers of oocytes are n=15–30. Significant changes (p,0.001, p,0.05) are indicated by *** (p=0.00015) and
* (p=0.036), respectively. (C) Representative samples including controls from uninjected oocytes were biotinylated to isolate plasma membrane
GluA1, then separated on an SDS gel, Western-blotted and probed with a primary rabbit anti-GluA1 antibody. The GluA1 protein has an apparent
molecular weight of ,105 kDa. (D) Bar graph showing relative abundance of GluA1 plasma membrane protein. The band intensity was quantified by
densitometric analysis using the software Scion image.
doi:10.1371/journal.pone.0033889.g004
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of GluA1 also involves myosin Vb, or if the SGK3 cascade
operates in a parallel modulatory pathway. To this end we
coexpressed GluA1 with myosin Vb, or a myosin Vb mutant
(myosin del) with inhibited ability to bind to Rab11/Rab111FIP2,
either with or without SGK3. The results shown in Figure 5C
indicate that the SGK3 effect on GluA1 trafficking does not
depend on myosin Vb, at least not in this heterologous expression
system. We therefore conclude that the SGK3-stimulated Rab11-
dependent GluA1 regulation described here is different from that
discovered by Wang et al.
Decrease of synaptic GluA1 receptors after treatment
with a PIKfyve inhibitor
After showing modulation of GluA1 trafficking by SGK3, we
explored whether the synaptic or extrasynaptic fraction of GluA1
subunits is affected via this signaling cascade, upon NMDA receptor
activation. Therefore, we analyzed cultured hippocampal neurons
for GluA1 expression under various conditions of pharmacological
NMDA receptor activation. To this end neurons were stained with
primary anti-GluA1 antibody and anti-neuroligin-1 antibody as
postsynaptic marker for non-permeabilized neurons (Figure 6), or
anti-PSD95 for permeabilized neurons (Figure S1). Utilizing
confocal laser scanning microscopy non-permeabilized neurons
were analyzed by counting neuroligin-stained as well as GluA1-
labeled spines and calculating the percentage of overlapping
expression of neuroligin with GluA1 with the aid of the Zeiss
physiology kit (Figure 6C). Hippocampal neurons were incubated
with 10 mM NMDA and 3 mM PIKfyve inhibitor (YM201636), or
30 mM SGK inhibitor (EMD638683), either alone or together for
20 minutes each, prior to fixation. As a control we used untreated
neurons. Incubation with NMDA clearly increased overlapping
expressionofneuroliginorPSD95withGluA1atsynapses(Figure6,
Figure 5. The SGK3-dependent trafficking of GluA1 proteins
requires functional RAB11 and the generation of PI(3,5)P2, but
is myosin-independent. (A) GluA1 current amplitudes in oocytes
before and after acute injection of a water-soluble analog of PI(3,5)P2.
Significant change (p,0.05) is indicated by * (p=0.0015). (B) GluA1
current amplitudes in oocytes expressing GluA1 or combinations of
GluA1 with Rab11 or the dominant negative form of Rab11 (Rab11DN),
before and after acute injection of a water-soluble analog of PI (3,5)P2.
Numbers of oocytes are n=7–28. Significant change (p,0.05) is
indicated by * (p=0.025). (C) GluA1 current amplitudes in oocytes
expressing GluA1 or combinations of GluA1 with SGK3, myosin Vb, or
the mutated form of myosin Vb (myosin del). Number of oocytes are
n=14–28.
doi:10.1371/journal.pone.0033889.g005
Figure 6. Reduced GluA1 expression after treatment with an
SGK inhibitor or a PIKfyve inhibitor. (A, B) Statistical analysis of
GluA1 surface expression and colocalization of GluA1 with neuroligin
revealed increased surface and synaptic GluA1 expression after
treatment with NMDA. This effect is abolished by SGK or PIKfyve
inhibition. Control=untreated, NMDA=incubated with NMDA, PIK-
In=treated with PIKfyve inhibitor, SGK-In=treated with SGK inhibitor.
(C–H) Representative confocal images of dendrites stained with GluA1
(green) and neuroligin (red –Neuro) in controls versus NMDA-treated
neurons under different conditions: (C) control versus (D) NMDA, (E)
PIKfyve inhibitor (PIK inhibitor), (F) PIKfyve inhibitor and NMDA (PIK
inhibitor+NMDA), (G) SGK inhibitor (SGK inhibitor), (H) SGK inhibitor
and NMDA (SGK inhibitor+NMDA). The magnification is equal for all
images - scale bar indicates 5 mm. Number of images analyzed n=10–
15, obtained from independent neuron culture preparations.
doi:10.1371/journal.pone.0033889.g006
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SGK inhibitor reduced synaptic expression of GluA1. These
observations suggest a regulatory role for an NMDA receptor-
triggered SGK3-PIKfyve-dependent cascade in synaptic expression
of GluA1 receptors.
Basal synaptic transmission is reduced by a PIKfyve
inhibitor
To explore the consequences of the observed signaling cascade
for evoked potentials, we performed electrophysiological experi-
ments on hippocampal slices to analyze basal synaptic transmis-
sion under normal conditions and during incubation with a
PIKfyve inhibitor. We evoked field excitatory postsynaptic
potentials (fEPSP) by stimulating the Schaffer collaterals and
recording from the CA1 Stratum radiatum. Control responses
(n=8) and responses obtained in the presence of DMSO (vehicle,
n=8) were stable throughout the recording period (Figure 7).
Basal synaptic transmission was significantly reduced, however, by
the PIKfyve inhibitor YM201636 (n=6). (ANOVA:
F(1,24)=50,56, p,0.001). This observation further supports a
regulatory role of PIKfyve on synaptic glutamate receptor
expression.
Discussion
In the past few years, it has become increasingly clear that
dynamic regulation of AMPA-type receptors at the synapse plays a
critical role in alterations of synaptic strength (for review: [2,3]).
AMPA receptors undergo constant trafficking in and out of
synapses by a combination of endocytotic retrieval, membrane-
directed transport, and lateral diffusion in the membrane.
Although the underlying mechanisms are far from being fully
understood, it is safe to state that all three processes participate in
receptor exchange at synapses at rest and during various forms of
plasticity [26]. The trafficking of AMPA receptors can occur
within minutes [27]. Protein phosphorylation plays a central role
in controlling AMPA receptor expression at the synapse and in
regulating synaptic strength [28,29]. The multiple signaling
pathways underlying the regulation of AMPA receptor trafficking
include the phospatidylinositol-3-kinase (PI3-kinase) pathway [30].
Downstream targets of the PI3-kinase include the phosphoinosi-
tide-dependent kinases PDK1, protein kinase B as well as the
serum- and glucocorticoid-inducible kinase isoforms including
SGK3. SGK3 is abundantly expressed in the brain and
upregulates GluA1 plasma membrane expression [8]. Our findings
suggest a novel principle for synaptic regulation which involves
modulation of GluA1 expression levels by SGK3 as a key feature.
Recently, increased attention has been directed towards PIKfyve,
whose importance for regulation of ion channel trafficking
becomes more and more apparent [17,18,19,20,21,22,23].
PIKfyve is phosphorylated at position Ser318 by SGK1 [23]
and, as shown in this study, is also phosphorylated at this site by
SGK3. Phosphorylation of Ser318 of PIKfyve leads to its
activation and increased PI(3,5)P2 production [17]. The effects
of SGK3 on GluA1 current amplitudes were mimicked by
overexpression of PIKfyve and abrogated by site-directed
mutagenesis that replaced Ser318 by Ala. Furthermore, GluA1
receptor currents were enhanced in response to injection of
PI(3,5)P2. The effect of SGK3 on GluA1 was not additive to that
of PIKfyve, indicating that PIKfyve is indeed a downstream target
of SGK3 (Figure 8). The observation that PI(3,5)P2 plays a
regulatory role in this cascade is especially interesting, as the role
of PI(3,5)P2 in regulation of glutamate receptors has never before
been explored. However, it has been reported by Arendt et al. that
synthesis and availability of phosphatidylinositol-(3,4,5)-trispho-
sphate (PI(3,4,5)P3) at the postsynaptic terminal is a precondition
for sustained synaptic function by maintaining AMPA receptor
clustering in hippocampal neurons [31]. PIP3 downregulation led
to a depression of synaptic transmission and impaired PSD-95
accumulation in spines. It remains to be elucitated if the
PI(3,4,5)P3 –dependent regulation of AMPA receptors, as
observed by Arendt et al., underlies the same regulatory
mechanism observed by us for GluA1, a mechanism which,
however, is PI(3,5)P2–dependent. Our experiments with myosin
Vb indicate myosin-independent regulation and thus a different
regulatory mechanism than shown by Wang et al. (2008).
The mechanism proposed in this study is based on the
observation that NMDA receptor activation in mouse hippocampi
triggers transcriptional stimulation of SGK3. It seems that the
relevant phospholipid PI(3,5)P2 is selectively and efficiently
Figure 7. PIKfyve inhibition results in depression of hippo-
campal basal synaptic transmission. (A) Basal synaptic transmis-
sion was recorded in the CA1 region of hippocampal slices. Control
(non-treated) hippocampi, or hippocampi treated with DMSO showed
stable evoked responses throughout the 210 min recording period.
Treatment with the PIKfyve inhibitor (YM201636) elicited a depression
of evoked responses that became evident 40 min after drug
application. Line-breaks indicate changes in time-scale. Black bar
indicates DMSO or drug application. (B) Analog traces representing
evoked potentials obtained in control slices or in slices in the presence
of DMSO or YM201636, at the time-points indicated in the graph.
Vertical scale-bar, 3 mV; horizontal bar, 3 ms.
doi:10.1371/journal.pone.0033889.g007
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The specific localization of PIKfyve at these recycling vesicles
enables production of this rare form of PIP2 specifically at these
vesicles. The fact that inhibition of SGK3 and PIKfyve were both
able to inhibit the translocation to the plasma membrane suggests
a key role for SGK3 and PIKfyve in this scenario (Figure 8).
Although, theoretically, PI(3,5)P2 can also be produced by PI3K in
vitro, PI3 kinase has not been reported being expressed in these
recycling vesicles. Therefore, PI3K involvement in the mechanism
described here could be negligible.
In summary, our observations suggest that NMDA receptor-
triggered SGK3 mRNA upregulation, SGK3-mediated phosphor-
ylation of PIKfyve and subsequent PI(3,5)P2 production act to
regulate AMPA receptor channel expression via Rab11-dependent
vesicle trafficking.
Materials and Methods
Molecular biology
cDNAs, vectors, and lipids. The following cDNAs were
used: GluA1/pSGEM, SGK3/pGHJ, PIKfyve and PIKfyve
(S318A)/pCDNA3.1, Rab11 and Rab11(S25N)/pCDNA3.1
(from D. Marks and E. Pagano), and myosin and myosin
delRBD(del1797-1811)/pCDNA6b-His/V5 (from M.D. Ehlers).
PI(3,5)P2-DIC8 (P4508) was purchased from Echelon Bioscience
Inc. (Salt Lake City, USA).
cRNA synthesis. Template DNA was linearized with a
suitable restriction enzyme. cRNA was synthesized from 1 mgo f
linearized DNA using an in vitro transcription kit (mMessage
mMachine T7 kit, Ambion Ltd., Cambridgeshire, UK). cRNA
concentrations were evaluated by photospectrometry, and
transcript quality was checked by agarose gel electrophoresis.
Purification of total RNA from brain tissue, RT-PCR and
quantitative RT-PCR analysis
C57/BL6 mice were anaesthetised with ether and then
decapitated. Brains were dissected in ice-cold PBS. Immedi-
ately after preparation, transverse slices (350 mm) were cut with
a vibratome and allowed to recover in a custom built
submerged chamber with oxygenated PBS (95%O2/5%CO2)
solution at 22u–25uC for 60 min before incubation with or
without 10 mM NMDA. Slices were then nitrogen-frozen and
stored at 280uC.
Total RNA was purified using the RNeasy Lipid Tissue Kit
from Qiagen (Qiagen, Hilden, Germany) according to the
manufacturer’s recommendation (RNeasy Lipid Tissue Hand-
book). Brain tissue was nitrogen-frozen immediately after surgery.
For homogenization 1 ml of Qiazol Lysis Reagent (Qiagen) was
used for each sample. For DNAse removal the on-column DNAse
digestion was performed according to the manufacturer’s
description. Total RNA was eluted with 30 ml DEPC water. The
total RNA of 4 samples were pooled, concentrated to lower
volume by speed vacuum centrifugation and frozen at 280uCf o r
storage.
For cDNA first strand synthesis, 1 mg of total RNA in 12.5 ml
DEPC-H2Ow a sm i x e dw i t h1mlo fo l i g o - d Tp r i m e r( 5 0 0mg/
ml, Invitrogen, Darmstadt, Germany) and heated for 2 min at
70uC. An RT mix of 2 ml1 0 6 reaction buffer (Biolabs,
Frankfurt, Germany), 1 mld N T Pm i x( d A T P ,d C T P ,d G T P ,
dTTP, 10 mM each, Promega, Mannheim, Germany), 0.5 ml
recombinant RNase inhibitor (Roche, Mannheim, Germany),
0.1 ml M-MuLV reverse transcriptase (Biolabs, Frankfurt,
Germany), and 2.9 mlD E P C - H 2O was then added and the
reaction mixture incubated for 60 min at 42uC. The reaction
was stopped by heating the mixture for 5 min at 94uC. The
cDNA was stored at 220uC until PCR analysis. PCR analysis
was then performed with 1 ml of the reverse transcription
product in a total volume of 25 ml of a PCR mix containing
22 mlo fs t e r i l eH 2O, 1 ml of primer 1 (10 pmol/ml), 1 mlo f
primer 2 (10 pmol/ml), and 1 puReTaq Ready-To-Go PCR
bead (Amersham Biosciences, Freiburg, Germany) through 40
cycles (30 s at 94uC; 30 s at 60uC; 45 s at 72uC). The following
primers were used to amplify a 315 bp stretch of the PIKfyve
isoform, bridging exons 19 and 20: sense primer: 59-CACTTG-
GGCACTTGCCACA-39; antisense primer: 59-CTCCGTCA-
GAAGATAGGAATG-39. For control reaction to exclude
genomic contamination the following primers were used binding
in intron 19 and exon 20: sense primer: 59-TCATCTTAAG-
CATATAATCA-39; antisense primer: 59- TCAGAGCCTC-
CTCTGAGCTTG-39. PCR products were analyzed by agarose
gel electrophoresis.
For quantitative RT-PCR, 2 mg of total RNA was reverse-
transcribed with Superscript II Reverse Transcriptase (Invitrogen,
Darmstadt, Germany). For subsequent PCRs, cDNA from 50 ng
of total RNA for quantitative PCR with a LightCycler Fast Start
DNA Master Plus SYBR Green I kit (Roche, Mannheim,
Germany) was used for a single reaction. Real-time PCRs were
performed on a Roche LightCycler (Roche, Mannheim, Ger-
many). Analysis was done using Roche LightCycler Software
(version 3.5). b-actin was used as a house-keeping/control gene.
SGK3 primer sequences used were: sense primer: 59-ATGCA-
GAGGGATTGTATCATGG-39; antisense primer: 59-TCTT-
GGCAGGAATCTTCAGAGC-39. b-actin primer sequences
used were: sense primer: 59-CGTTGACATCCGTAAAGAC-
CT-39; antisense primer: 59-CAAAGCCATGCCAATGTT-
GTCTCT-39.
Figure 8. Postulated model of SGK3-dependent regulation of
GluA1. Upon stimulation of NMDA receptors SGK3 is transcriptionally
upregulated. SGK3 in turn phosphorylates/activates PIKfyve, which
leads to local production of PI(3,5)P2 in PIKfyve-containing recycling
vesicles. PI(3,5)P2 in turn stimulates Rab11-dependent plasma mem-
brane-directed trafficking of GluA1-containing vesicles.
doi:10.1371/journal.pone.0033889.g008
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and SGK3
Wild-type and mutant (S318A) GST-PIKfyve (amino acids 1–
497) were expressed in E. coli and purified using glutathione-
Sepharose beads essentially as previously described [23]. The
beads (10 to 20 mL) were incubated with 20 mU of PKB or SGK3
(Upstate, Dundee, UK) in phosphorylation buffer (20 mM MOPS
pH 7.2, 1 mM EDTA, 0.1% b-mercaptoethanol, 20 mM b-
glycerophosphate, 10 mM MgCl2, 500 mM ATP (0.05MBq [c-
32P]ATP per sample)) at 30uC for 20 minutes. Sample buffer was
added and the samples heated at 95uC for 5 minutes. Samples
were electrophoresed on a 4–12% Bis-Tris gel and transferred to
PVDF. The membrane was analysed by autoradiography and
probed with anti-pS318-PIKfyve and anti-GST antibodies as
previously described [23].
Electrophysiological measurements in Xenopus oocytes
Oocytes of stages V-VI were surgically removed from the
ovaries of Xenopus laevis as described elsewhere [34]. Oocytes were
injected with GluA1 cRNA (4 ng/oocyte) or together with SGK3
cRNA (6 ng/oocyte) using a nanoliter injector 2000 (WPI, Berlin,
Germany). Standard two-electrode voltage clamp recordings were
performed 5–7 days after cRNA injection with a TurboTec 03
amplifier (npi, Tamm, Germany) and an interface DIGIDATA
1322A from Axon Instruments (CA, USA). Data analyses were
done with pClamp/Clampex software 8.0 (Axon Inc., CA, USA)
and Origin 6.0 software (Additive, Friedrichsdorf, Germany).
Agonist solutions were prepared in ND-96 buffer (96 mM NaCl;
1.8 mM CaCl2; 2.0 mM KCl; 1.0 mM MgCl2, and 5 mM
HEPES-NaOH, pH 7.2 with NaOH, all from Sigma-Aldrich,
Munich, Germany). Current and voltage electrodes were filled
with 3 M KCl and had resistances of 0.5–1.5 MV. Oocytes were
held at 270 mV and agonist (300 mM glutamate; Tocris, Cologne,
Germany) was applied by superfusion for 10 s at a flow rate of 10–
14 ml/min.
Isolation of cell surface proteins after biotinyl-ConA
modification
To identify the fraction of receptor protein inserted in the
plasma membrane, surface proteins were tagged with biotinylated
ConA (Sigma-Aldrich, Munich, Germany) and isolated by
streptavidin/sepharose-mediated precipitation of the biotinyl-
ConA/protein complexes as described elsewere [8]. Briefly, intact
oocytes were incubated in 10 mM biotinyl-ConA (Sigma, Munich,
Germany) for 30 min at room temperature. At this step the
biotinylated ConA binds to glycosylated plasma membrane
proteins, e.g. glutamate receptors. To remove excess biotinylated
ConA, oocytes were washed five times for 10 min in ND-96 buffer.
After washes, 20 intact oocytes were homogenized with a Teflon
pestle in H-buffer (20 ml/oocyte; 100 mM NaCl, 20 mM Tris-
HCl, pH 7.4, 1% Triton X-100, plus a mixture of proteinase
inhibitors (Complete; Boehringer Mannheim, Mannheim, Ger-
many)) and were kept at 4uC for 1 hr on a rotating rod. Since
exclusively intact oocytes were used for homogenization, only
plasma membrane proteins, not proteins of internal membranes,
were labelled. After centrifugation of the remaining homogenate
for 1 min at 16,000 g, the supernatants were supplemented with
20 ml of washed streptavidin-sepharose beads (Sigma, Munich,
Germany) and incubated at 4uC for 3 hrs on a rotating rod.
During this step, the streptavidin beads bound to the biotinyl-
ConA-plasma membrane receptor complex. The streptavidin-
sepharose beads were then pelleted by a 2 min spin at 16,000 g
and washed three times in H-buffer. The final pellets, containing
plasma membrane receptors, were boiled in 20 ml of SDS-PAGE
loading buffer (0.8 M ß-mercaptoethanol, 6% SDS, 20% glycerol,
25 mM Tris-HCl, pH 6.8, and 0.1% bromphenol blue).
Gel electrophoresis and Western blotting
Proteins from homogenized oocytes were separated by SDS
polyacrylamide gel electrophoresis and transferred to nitrocellu-
lose filters. Blots were blocked in 16 PBS containing 5% milk
powder for at least 1 hour at room temperature. For the detection
of GluA1, rabbit anti-GluA1 antibody (kind gift of R. Huganir)
and secondary horseradish peroxidase-conjugated donkey anti-
rabbit antibody (1:1000 dilution, Amersham Bioscience, Freiburg,
Germany) were used.
Statistical analysis
For the immunoblotting studies, representative immunoblots
are shown and a quantitative assessment of plasma membrane
abundance was obtained by densitometric analysis of immunoblots
from similar experiments. Before pooling the results from different
blots, data from each blot were expressed as a percentage of the
control value (relative abundance). The combined data from all
blots were then expressed as the mean 6 SEM. Statistical analyses
of the data were performed by Origin 6.0. Experiments were
analyzed by ANOVA, and p,0.05 was considered statistically
significant.
Primary hippocampal cell culture
New-born wild type Wistar rats of post-natal day 0–2 (P0–P2)
were used for cultivation of primary rat hippocampal neurons.
Primary hippocampal neurons were prepared according to a
similar protocol as described by Lessmann and Heumann [35].
Briefly, the hippocampi of P0–P2 new-born Wistar rats were
minced in ice cold MPBS+/+ (modified phosphate-buffered saline
supplemented with 0.25 mM CaCl2, 5.8 mM MgCl2,1 0 m M
HEPES, 1 mM sodium pyruvate, 6 mg/ml DNaseI, 1 mg/mL
bovine serum albumin (BSA), 10 mM glucose, 25 U/mL penicil-
lin, 25 mg/ml, streptomycin, 2 mM glutamine, 5 mg/mL phenol
red, 4 mM NaOH) and digested with 10% trypsin in MPBS2/2
(MPBS+/+ without CaCl2 and MgCl2) for 7 min while shaking at
37uC. After settling of the tissue, the supernatant (containing
dissociated cells) was diluted two-fold with RPMI/10% FCS
(2 mM glutamine, 10% fetal calf serum (FCS), 25 U/mL
penicillin, 25 mg/ml, streptomycin, 0.00375% insulin, 5 mM
glucose, 10 mM HEPES, in RPMI 1640 (PAA)) to terminate
digestion. Residual tissue pieces were dissociated by trituration in
MPBS2/2 with cut plastic pipette tips three times. The cells were
collected by centrifuging at 2006g for 10 min. The cells were
dissociated in RPMI/10% FCS, seeded at a density of 200,000
cells per 35 mm gelatine-coated glass cover slip and cultivated at
37uC and 5% CO2. The following day, the media was exchanged
against neurobasal medium (Invitrogen, Darmstadt, Germany)
containing B-27 serum-free supplement (Invitrogen) (16 B27,
2 mM glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin
in neurobasal medium). Every second to third day the media was
exchanged against fresh pre-incubated medium. The cells were
used for experiments after 10–14 days in vitro. The media was
removed and fresh full neurobasal medium without B-27 was
given to the cells 2 h prior to the stimulations. Hippocampal
neurons were stimulated by either 10 mM NMDA, 3 mM PIKfyve
inhibitor (YM201636; Chemdea, Ridgewood, NJ, USA), 30 mM
SGK3 inhibitor (EMD638683; Merck KGaA, Darmstadt, Ger-
many), or both for 20 minutes each. Finally, the cells were fixed
with 4% paraformaldehyde in PBS.
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For immunohistochemistry hippocampal neurons were fixed in
4% paraformaldehyde. The neurons were either incubated with
1% Triton X-100 in PBS (permeable condition) or in PBS only
(non-permeable condition) for 15 min. Thereafter, cell cultures
were washed three times in PBS and incubated with primary
rabbit anti-GluA1 antibody (kind gift of R. Huganir) and mouse
anti-PSD95 antibody (Thermo Scientific, Rockford, IL, USA,
#MA1-046), or primary rabbit anti-GluA1 antibody (Alomone,
Jerusalem, Israel, #AGC-004) and mouse anti- neuroligin-1
antibody (Millipore, Temecula, CA, USA, #MABN38) overnight
at 4uC. PSD95 and neuroligin-1 antibodies were used as
postsynaptic neuronal markers (PSD95 for intracellular and
Neuroligin-1 for extracellular staining). Afterwards, to block
nonspecific binding sites, cultures were treated with 10% (w/v)
normal goat serum in PBS for 30 min. The samples were then
reacted with the secondary antibodies for 2 h at room temperature
(goat anti-mouse IgG-TRITC, T5393; goat anti-rabbit IgG-FITC,
F6005, Sigma, Munich, Germany). Finally, cultures were rinsed in
PBS and coverslipped in Moviol (Aventis, Hoechst, Germany).
Samples were evaluated by confocal laser scanning microscopy
(Zeiss LSM 510 META, Oberkochen, Germany) in the multi-
tracking sequential mode set for detection of FITC and TRITC
with the appropriate emission bandpass filters in combination with
Zeiss 406(Plan-Neofluoar, NA 1.3) oil immersion lenses and the
Zeiss physiology kit.
Analyses of immunhistochemistry
Surface expression of GluA1. The images were analyzed
using ImageJ (version 1,45 s Rasband, W.S., ImageJ, U.S.
National Institutes of Health, Bethesda, Maryland, USA, http://
imagej.nih.gov/ij/, 1997–2011) similar as described before [36].
The staining intensity of immunostainings depends on several
factors including the quality of the substrate and the background.
We tried to account for these influences in our analyses. The
intensities of green (GluA1 - Gi) and red (neuroligin - Ni)
fluorescence were determined using ImageJ in a square of about
1625 mm covering a region of a clearly identifiable dendrite and a
region outside the neuron. The intensities determined outside the
neurons were regarded as background and subtracted from the
dendritic intensities. To account for variations in quality of the
substrates, like variances in morphology, we normalized the
GluA1 intensities to the neuroligin intensities by dividing Gi by Ni.
Percentage of colocalized GluA1. Using ImageJ the
intensities of a selected square of about 1625 mm were
calculated for the GluA1 and neuroligin images. The results
were transferred to Origin 6.0 and the profiles were overlaid.
Firstly, the clearly identifiable GluA1 peaks (Gc) of 0.3–3 mm size
indicating protein clusters were counted [36]. Secondly, the
peaks/clusters where GluA1 peaks overlapped with neuroligin
peaks/clusters of 0.3–3 mm sizes were counted as colocalized
clusters (cc). The percentage of colocalized GluA1 was calculated
by (cc/Gc)6100%.
Electrophysiology on hippocampal slices
Seven-to- ten week old male C57/BL6 mice were anaesthetised
with ether and then decapitated. Brains were dissected in ice-cold
artificial cerebrospinal fluid (aCSF) (containing in mM: NaCl, 124;
KCl, 4.9; KH2PO4, 1.2; MgSO4, 1.3; CaCl2, 2.5; NaHCO3, 25.6;
and d-glucose, 10). Immediately after preparation, transverse slices
(400 mm) were cut with a vibratome and allowed to recover in a
submerged chamber with oxygenated aCSF solution at 22u–25uC
for 1 h before recordings were commenced. Slices were then
transferred to a submerged recording chamber with continuously
perfused aCSF that was saturated with 95%O2/5%CO2 at 30uC.
The constant flow rate was ,1 mL/min. A bipolar stimulating
electrode was positioned in the Schaffer collaterals. Recordings of
field excitatory postsynaptic potentials (fEPSPs) were obtained via
a monopolar platinum-tipped silver chloride electrode that was
placed in the Stratum radiatum of the CA1 region.
Data were obtained by averaging five fEPSP responses
generated by test-pulse stimulation at 0.025 Hz (0.2 ms stimulus
duration, 16 KHz sample rate). For each time point, five evoked
responses were averaged. These time-points were timed to obtain
averaged responses every 5 or 15 minute intervals. The average of
the first 6 time-points acquired during the first 30 min was taken
as a baseline reference with which subsequent changes in evoked
responses were compared and calculated as a percentage value.
The slope of the field excitatory post-synaptic potential (fEPSP)
was measured as the maximal slope through the five steepest
points obtained on the first positive deflection of the potential. By
means of input/output curve determination the maximum fEPSP
slope was found for each individual animal, and all potentials
employed as baseline criteria were evoked at a stimulus intensity
that produced 30% of this maximum. The data were then
expressed as mean percentage preinjection baseline reading
6SEM. Statistical analysis was done using analysis of variance
(ANOVA) with repeated measures and significant was set to
p,0.05.
The phosphoinositol-3-phosphate-5-kinase (PIKfyve) inhibitor
YM201636 was dissolved in dimethylsulfoxide (DMSO) (10 mM
stock). After 40 min of baseline recordings, slices were continu-
ously perfused with YM201636 in a concentration of 2 mM. To
exclude independent effects of the vehicle, in a separate
experiment DMSO was applied in the same time-period as
YM201636. Effects were compared to slices that were neither
treated with YM201636 or DMSO.
Ethic Statement
New-born wild type Wistar rats and wild type C57/BL6 mice of
either sex were killed following protocols approved by the animal
welfare officer of the Ruhr-University Bochum in accordance with
the guidelines of the European Community (86/609/EEC). All
efforts were made to minimize animal suffering. The method for
hippocampus preparation has been described in detail elsewhere
[33].
Supporting Information
Figure S1 Reduced synaptic GluA1 expression after
treatment with a PIKfyve inhibitor. (A, B) Representative
confocal images of dendrites stained with GluA1 (green) and
PSD95 (red) in controls versus NMDA-treated neurons. (C)
Statistical analysis of colocalization of GluA1 and PSD95 revealed
reduced synaptic GluA1 expression after treatment with a PIKfyve
inhibitor. (D, E, F, G) Magnified views of representative dendritic
stainings with GluA1 and PSD95 in (D) control versus (E) NMDA,
(F) PIKfyve, (G) NMDA plus PIKfyve-treated neurons. The
arrows indicate co-localization of GluA1 and PSD95. Scale bars,
5 mm.
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